View Cart  

Senate BPCA, PREA Bill Bumps Up Deadlines, Grants FDA More Authority

A A
Drugmakers would need to submit pediatric study plans to the FDA sooner in the drug development process under a bipartisan Senate bill that would make three programs intended to encourage pediatric trials of medical products permanent.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00